TRPM2 Channel Involvement in the Hesperidin-Mediated Potentiation of Cisplatin’s Antitumor Action in Laryngeal Carcinoma Cells
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27031141 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ramazan Çınar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Faculty of Medicine, Bilecik Seyh Edebali University, 11230 Bilecik, Türkiye. Hauptthemen laut MEDLINE: TRPM Cation Channels, Hesperidin, Cisplatin, Laryngeal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cisplatin (CSP) is a first-line chemotherapeutic for laryngeal squamous cell carcinoma (LSCC), but its clinical effectiveness is limited by resistance and toxicity. Hesperidin (HESP), a citrus flavonoid, may enhance chemotherapeutic efficacy through pro-apoptotic properties. This study investigated the involvement of the transient receptor potential melastatin-2 (TRPM2) channel in the HESP-mediated potentiation of CSP-induced cytotoxicity in human laryngeal carcinoma (Hep-2) cells. Hep-2 cells were treated with CSP (25 µM), HESP (25 µM), or their combination for 24 h. The findings showed that the combined application of HESP and CSP reduced cell viability by approximately 50% (p < 0.001), which was the lowest compared to CSP alone. Western blot analysis revealed that TRPM2 protein expression was higher in the CSP+HESP group compared to the control group (p < 0.001). This synergistic treatment resulted in an increase in ROS production and a decrease in MDA levels, accompanied by a reduction in cellular GSH levels (p < 0.001). Furthermore, the combination therapy increased pro-inflammatory cytokines such as IL-1β and TNF-α (p < 0.001). Functional analyses showed that HESP treatment enhanced CSP-induced Ca2+ influx and altered mitochondrial membrane potential (p < 0.001). The pharmacological inhibition of TRPM2 with ACA and 2-APB reversed these effects, restoring redox balance and reducing cellular damage. In conclusion, HESP amplifies CSP-induced apoptosis in Hep-2 cells through TRPM2-dependent oxidative stress, Ca2+ dysregulation, and mitochondrial dysfunction. These findings identify TRPM2 as a mechanistic mediator of HESP-enhanced chemosensitivity in LSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biophysics, Faculty of Medicine, Bilecik Seyh Edebali University, 11230 Bilecik, Türkiye.
- Department of Biophysics, Faculty of Medicine, Van Yuzuncu Yil University, 65080 Van, Türkiye.
- Department of Otorhinolaryngology, Faculty of Medicine, Bilecik Seyh Edebali University, 11230 Bilecik, Türkiye.
ORCID-Profile: Ramazan Çınar, Kenan Yıldızhan, Tarık Yağcı
Zitieren
APA
Çınar, R., Yıldızhan, K., Altıner, H. İ., & Yağcı, T. (2026). TRPM2 Channel Involvement in the Hesperidin-Mediated Potentiation of Cisplatin’s Antitumor Action in Laryngeal Carcinoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031141
Vancouver
Çınar R, Yıldızhan K, Altıner Hİ, Yağcı T. TRPM2 Channel Involvement in the Hesperidin-Mediated Potentiation of Cisplatin’s Antitumor Action in Laryngeal Carcinoma Cells. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031141
BibTeX
@article{nar2026,
author = {Çınar, Ramazan and Yıldızhan, Kenan and Altıner, Halil İbrahim and Yağcı, Tarık},
title = {TRPM2 Channel Involvement in the Hesperidin-Mediated Potentiation of Cisplatin’s Antitumor Action in Laryngeal Carcinoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27031141}
}
EUVIMED